RTX Looks 23.3% Overvalued on GF Value™
RTX Corp (NYSE: RTX) secured a $105.6M contract modification for AMRAAM missile parts, funded by U.S. and international budgets. The company is trading at $190.99, 23.3% above its GF Value™ of $154.96, indicating modest overvaluation. RTX has a GF Score™ of 80/100, reflecting strong financial health but mixed insider activity.
How this was made
The 30-second read
Why it matters
The $105.6 M AMRAAM contract adds to RTX's order backlog and may support earnings growth in FY2027.
Market read
A new defense contract of this size is material for RTX and can influence short‑term sentiment in the defense sector.
What to watch
Potential delays in funding or execution risk could temper the contract's upside.
Background
RTX is a diversified aerospace and defense company with three main segments: Collins Aerospace, Pratt & Whitney, and Raytheon.
Ticker impact
RTX announced a $105.6 million firm‑fixed‑price contract modification for AMRAAM missile components.
Potential modest upside if the market prices the new contract into the stock.
A $105 M award is sizable for a large defense contractor and signals continued demand, but the stock already trades near historical multiples.
Market effects
Strengthens the aerospace & defense sector outlook as the contract reflects ongoing U.S. military procurement.
Positive for U.S. defense suppliers; limited impact on broader markets.
Reinforces demand for missile systems among allied nations, modestly relevant globally.
Counterpoint
Insider selling and modest overvaluation may signal caution despite the new contract.
Key entities
- CompanyRaytheon Technologies Corp.
Parent company of RTX.
- Government AgencyAir Force Life Cycle Management Center
Oversees the contract award.
